Ascites is the buildup of fluid in the abdominal cavity, which often develops as a complication of liver disease. However, ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

In contrast to LVP, which provides only symptomatic control and requires repeated procedures, TIPS efficiently prevents the formation of ascites and increases urinary sodium excretion by reducing ...

Chylous ascites (CA) is a rare condition caused by disruption of the lymphatic system, with the accumulation of milky ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEMENT, LINDIS HAS GRANTED PHARMANOVIA ...

Catumaxomab, a first-in-class therapeutic, is specifically designed to treat malignant ascites in adults with certain types of cancer (epithelial cellular adhesion molecule (EpCAM)-positive carcinomas ...